Clinical Trial Update: Phase I Study Evaluating Tolerability, Safety, Pharmacokinetics, and Efficacy of Combined ONO-4059 and R-MPV Therapy for PCNSL [Phase 1]

View source ↗

Summary

Phase I trial evaluating tolerability, safety, pharmacokinetics, and preliminary efficacy of combining ONO-4059 with the R-MPV regimen for primary central nervo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma

Drugs mentioned

• ONO-4059
• R-MPV therapy

Snippet

Sponsor: Ono Pharmaceutical Co., Ltd. | Conditions: Primary Central Nervous System Lymphoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING